Inventor · disambiguated record
Philip V. Felice
Also filed as: FELICE PHILIP · FELICE PHILIP V
13 granted patents·14 pending applications·65 citations·filing 2009–2024
91Inventor score
Top patents by PatentIndex Score
27 records- 0195US8173625B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2009·Granted May 8, 2012·32 cites·8 claims
- 0294US9603937B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2015·Granted Mar 28, 2017·6 cites·3 claims
- 0391US8304404B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2012·Granted Nov 6, 2012·10 cites·10 claims
- 0490US9603938B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·3 claims
- 0589US12268783B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2021·Granted Apr 8, 2025·1 cites·4 claims
- 0689US9603939B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·3 claims
- 0788US2025228778A1Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0881US9289440B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Granted Mar 22, 2016·2 cites·14 claims
- 0981US8685948B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2013·Granted Apr 1, 2014·2 cites·16 claims
- 1080US9289438B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2014·Granted Mar 22, 2016·2 cites·16 claims
- 1180US9289439B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2014·Granted Mar 22, 2016·2 cites·16 claims
- 1280US8476250B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2013·Granted Jul 2, 2013·2 cites·24 claims
- 1376US2025134912A1Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of useTHEAPRIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1475US2023111210A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1575US2023115710A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate ,and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1675US2023201147A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1775US2023201152A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1875US2023110872A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1971US2023149427A1Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of useTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2067US2014296189A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2167US2014343021A1Adjuvant to thrombolytic therapy for the treatment of frostbiteTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2267US2014235594A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2364US2018064649A1Platform drug delivery system utilizing crystal engineering and theanine dissolutionBRITTAIN HARRY G·Filed 2016·Application pending·0 cites
- 2464US2020101010A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2563US10376464B2Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Aug 13, 2019·0 cites·12 claims
- 2663US2013012482A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2761US9896411B2Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Feb 20, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Philip V. Felice files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →